These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 2935903

  • 1. The hematologic consequences of thrombolytic therapy.
    Fletcher AP, Alkjaersig NK.
    Prog Hematol; 1986; 14():183-200. PubMed ID: 2935903
    [No Abstract] [Full Text] [Related]

  • 2. Thromboelastographic study of fibrinolytic agents.
    Summaria L.
    Semin Thromb Hemost; 1995; 21 Suppl 4():63-71. PubMed ID: 8747691
    [No Abstract] [Full Text] [Related]

  • 3. Thrombolytic therapy.
    Kakkar VV, Scully MF.
    Br Med Bull; 1978 May; 34(2):191-9. PubMed ID: 148935
    [No Abstract] [Full Text] [Related]

  • 4. Coronary thrombolysis: hemorrhagic complications.
    Hirsh J.
    Can J Cardiol; 1993 May; 9(6):505-11. PubMed ID: 8221344
    [No Abstract] [Full Text] [Related]

  • 5. Theoretic and practical considerations on laboratory monitoring of thrombolytic therapy.
    Conard J, Samama MM.
    Semin Thromb Hemost; 1987 Apr; 13(2):212-22. PubMed ID: 3114887
    [No Abstract] [Full Text] [Related]

  • 6. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
    Kwaan HC.
    Thromb Diath Haemorrh Suppl; 1973 Apr; 56():239-51. PubMed ID: 4617331
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacology of thrombolytic agents. Implications for therapy of coronary artery thrombosis.
    Marder VJ.
    Circulation; 1983 Aug; 68(2 Pt 2):I2-5. PubMed ID: 6683134
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
    Marder VJ, Francis CW.
    Prog Hemost Thromb; 1984 Aug; 7():325-56. PubMed ID: 6241729
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Thrombolytic treatment of thromboembolytic conditions].
    Gormsen J.
    Ugeskr Laeger; 1966 Oct 20; 128(42):1235-45. PubMed ID: 4231392
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Current developments in thrombolytic therapy using novel plasminogen activators.
    Seifried E, Tanswell P.
    Arzneimittelforschung; 1989 Nov 20; 39(11):1474-82. PubMed ID: 2695093
    [Abstract] [Full Text] [Related]

  • 18. Fibrinolytic agents and their effects on the haemostatic system.
    Kluft C.
    Klin Wochenschr; 1988 Nov 20; 66 Suppl 12():50-4. PubMed ID: 2964542
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.